Robert Wood Johnson University Hospital — New Brunswick, New Jersey

Public research footprint of Robert Wood Johnson University Hospital, compiled from the ClinicalTrials.gov public registry.

361

Registered studies

170

Active

Recruiting now

153

Completed

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Fallopian Tube Carcinoma · Recurrent Primary Peritoneal Carcinoma · Breast Ductal Carcinoma In Situ

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06064097 — A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal… (Recruiting)
NCT04181060 — Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Robert Wood Johnson University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.